Our relentless dedication to accuracy, timeliness and regulatory rigor enables your biotherapeutic innovations to reach patients faster.
Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics & Pharmacodynamics (PK/PD)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
In association with Bioanalysis Zone, this webinar will highlight how bioanalytical strategies for implementing biomarkers in clinical trials will be presented. The increased use of biomarkers, within different steps of the drug development process, has led to greater demands within the bioanalytical lab community to support the related biomarker method validation and bioanalytical needs.
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
September 16, 2021Update on CAR T-Cell Therapies for the Treatment of Cancer
September 15, 2021Challenges for Measuring Immunogenicity of AAV-based Gene Therapies
August 26, 2021For the 8th Time, BioAgilytix Named to Inc. 5000 Annual List of America’s Fastest-Growing Private Companies
August 18, 2021MicroConstants to Join BioAgilytix Family
August 6, 2020Analytical Assays Determine Biosimilar Product Quality
December 2, 2019Immunogenicity Assessment of Gene Therapy Compounds
Services
Platforms
